Kresten Skak is an experienced life-science leader and immunologist with extensive expertise in research and early clinical development, gained from roles at LEO Pharma, Novo Nordisk, Nykode Therapeutics, and Dragonfly Therapeutics. Currently serving as Senior Director, Head of Preclinical Pharmacology at Commit Biologics, they lead in vivo pharmacology efforts. With a strong foundation in immunology and in vivo pharmacology, Kresten has successfully managed teams and driven drug discovery initiatives across various therapeutic areas, including oncology and autoimmune diseases. Their leadership style emphasizes trust and empowerment, while consistently adapting to the dynamic nature of the industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices